Last Updated: 05/12/23
Screening/Hit-to-Lead Stage NExT Projects
| Applicant | Institute | Project |
|---|---|---|
| Stauffer, Shaun | Cleveland Clinic Foundation | Discovery of Inhibitors of Oncogenic Hippo Pathway Signaling |
| Zhou, Pengbo | Weill-Cornell | CUL4 Inhibitors as Dual Precision Oncology and Immuno-oncology Drugs |
| Emerling, Brooke | Sanford Burnham Prebys | PI5P4K inhibitors for the treatment of TP53 mutant breast cancer |
| Fesik, Stephen | Vanderbilt University | Discovery of Small Molecule, Direct Inhibitors of Oncogenic Wnt Signaling |
| Fesik, Stephen | Vanderbilt University | Tissue specific target degradation using PROTACs |